Cite
HARVARD Citation
Tuttle, K. et al. (2018). Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial. Lancet. 6 (8), pp. 605-617. [Online].